MedTrace Logo

Algae and Cholesterol Absorption

NCT03380611 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-10-19

No results posted yet for this study

Summary

The primary objective of this study is to investigate the effects of wakame and spirulina consumption on intestinal cholesterol absorption.

Conditions

  • Intestinal Cholesterol Absorption

Interventions

DIETARY_SUPPLEMENT

Wakame

Consumption of 4.8 grams wakame per day for 17 days

DIETARY_SUPPLEMENT

Spirulina

Consumption of 4.8 grams spirulina per day for 17 days

DIETARY_SUPPLEMENT

Control

Consumption of microcrystalline cellulose for 17 days

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Ronald Mensink, Professor · Maastricht University Medical Center

  • Jogchum Plat, Professor · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-24
Primary Completion
2018-08-16
Completion
2018-08-16

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380611 on ClinicalTrials.gov